|
|
|
|
|
Menu Options
Home
Page
Medical Advisory Board
Board of
Directors
Contact Us
Company
Careers
Corporate
Headquarters
350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806 |
|
Joseph Feldschuh, M.D.,
Chairman of the Board, CEO |
|
Dr. Feldschuh has
been President of Daxor since 1974. He is on the staff of Montefiore
Hospital and Medical Center. From 1966 to 1983, Dr. Feldschuh was Director
of the Cardiac Metabolic Laboratory at Metropolitan Hospital. He has been
a Clinical Associate Professor at Cornell Medical School. He performed the
basic research at the College of Physicians and Surgeons (Columbia
University) on the measurement and prediction of normal human blood
volume. He is the co-inventor of the Blood Volume Analyzer and the
inventor of the quantitative injection kit for the BVA-100. He is Board
Certified in Cardiology and Internal Medicine. |
|
James A. Lombard,
Director of the Company |
|
James A. Lombard
holds an undergraduate degree in Business Administration (BBA) from Iona
College and a Master's Degree (MBA) in Marketing, Banking, and Finance
from New York University Graduate School of Business Administration. Mr.
Lombard recently retired as Director, Administrative Services Division,
City Council of New York and actively participates in civic and community
affairs. Prior to joining the City Council, he worked in the field of
banking, holding various administrative positions with Citicorp and other
major Banking institutions. |
|
Martin S. Wolpoff,
Director of the Company |
|
Martin S. Wolpoff
holds B.A., M.A. and M.S. degrees from the City University of New York. He
has been active in community affairs since the 1970's. He has served on
his local community Board (as a member for over two decades and its chair
for three years), community School Board (member for nine years, president
for three), Community Development Corporation (member for almost 10
years), and a member of the community advisory board for a New York City
hospital. Mr. Wolpoff is retired from the New York City public school
system, having served since 1965 as an educator, supervisor, and
administrator. He is currently an educational consultant. |
|
Robert Willens, Director
of the Company |
|
Robert Willens
is a Managing Director in the Mergers & Acquisition department at Lehman
Brothers, Inc., in New York. Mr. Willens specializes in tax and accounting
issues and in this capacity advises most areas of the firm regarding the
optimal structures for corporate capital transactions. In addition, he has
been instrumental in developing certain financial products with a view
towards insuring that these products will provide clients with the desired
tax and accounting results. Prior to joining Lehman Brothers (in 1987),
Mr. Willens was a tax partner in the New York office of what was then
known as Peat Marwick. Mr. Willens is a prolific author and has written
Taxation of Corporate Capital Transactions, as well as over 200
articles for various professional journals. Each year of the past 10
years, Mr. Willens has been named to Institutional Investor's "All
American Research" Team. For the past 4 years, Mr. Willens was named by
Accounting Today as one of the 100 Most Influential Accountants in the
United States. Mr. Willens serves as an Adjunct Professor (Finance
Department) at Columbia University's Graduate School of Business where he
teaches the course titled "Investment Banking Tax Factors." He is a member
of the Board of Advisers of Columbia Capital Management. |
|
Bernhard Saxe,
Director of the Company |
|
Bernhard Saxe is a retired
partner of Foley & Lardner, LLP,
a general intellectual property
practice, and former Vice
President of Patent Affairs and
Corporate Secretary of
Immunomedics, Inc. He is a
registered patent attorney and a
member of American Intellectual
Property Law Association,
American Bar Association and
American Chemical Society. He
received his J.D. from George
Washington University; NIH
Postdoctoral Fellowship in
Strasbourg, France; PhD from
Columbia University; and his
B.A. from Johns Hopkins
University in chemistry. Mr.
Saxe is listed among the top 10
patent prosecuting attorneys in
Patent Hall of Fame: A Teacher’s
Tale, has authored multiple
articles pertaining to patent
law and participated in various
seminars and lectures. |
|
Stanley Epstein, M.D.,
Director of the Company |
|
Stanley Epstein, M.D., is a board
certified cardiologist, received
his medical degree from Chicago
Medical School and is licensed
to practice medicine in New York
State and California. Dr.
Epstein currently is clinical
professor of medicine at the
College of Physicians and
Surgeons of Columbia University
and associate clinical Professor
of Medicine at Albert Einstein
College of Medicine. He is
currently an attending physician
at Presbyterian Hospital in New
York, associate attending at Montefiore in the Bronx and
attending physician at Lawrence
Hospital in Bronxville. Dr.
Epstein has received numerous
awards and recognitions for both
medicine and teaching in the
field of internal medicine. |
|
Mario Biaggi, Jr.,
Director of the Company |
|
Mario Biaggi, Jr. is a graduate
of Fordham Prep where he was a
Maroon Key Honor Society Member
as well as Columbia College and
Columbia Law School where he was
the winner of the Frank Hogan
Scholarship named in honor of
the legendary Manhattan District
Attorney. He graduated Phi Beta
Kappa, Cum Laude from Columbia
College. Mr. Biaggi was admitted
to the bar of the State of New
York and later established the
law firm of Biaggi & Biaggi with
his brother. Mr. Biaggi is an
accomplished civil trial
attorney who has worked for a
variety of public and private
clients including the State of
New York and the United
Federation of Teachers, to name
a few. Mr. Biaggi was elected
and re-elected as a judicial
delegate in Bronx County and is
a past member of the Board of
Directors of the Abbott House, a
childcare agency and residential
treatment center. |
|
|